Borderline resectable pancreatic cancer: need for standardization and methods for optimal clinical trial design.

Katz MH, Marsh R, Herman JM, Shi Q, Collison E, Venook AP, Kindler HL, Alberts SR, Philip P, Lowy AM, Pisters PW, Posner MC, Berlin JD, Ahmad SA
Ann Surg Oncol. 2013 20 (8): 2787-95

PMID: 23435609 · PMCID: PMC5600517 · DOI:10.1245/s10434-013-2886-9

MeSH Terms (8)

Adenocarcinoma Clinical Trials as Topic Humans Neoadjuvant Therapy Pancreatectomy Pancreatic Neoplasms Patient Selection Research Design

Connections (1)

This publication is referenced by other Labnodes entities:

Links